• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Advancing epilepsy research: Insights from Truveta’s epilepsy data

Advancing epilepsy research: Insights from Truveta’s epilepsy data

by Truveta staff | Sep 22, 2023 | Data

Epilepsy is a complex neurological disorder, characterized by recurrent, unpredictable seizures. The fourth most common neurological disorder in the world, an estimated 3.4 million (3M adults and 470,000 children) have active epilepsy in the US. These seizures...

Share this


Recent posts

  • How Truveta benchmarks AI model quality for clinical concept extraction
  • Truveta Data analysis shows improved outcomes with Impella support in high-risk heart procedures
  • Evaluating recent trends in early measles vaccinations in Texas

Follow Truveta


Sign up for our newsletter

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice